BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $13,198,132 | +56.9% | 111,312 | +82.3% | 0.02% | -13.6% |
| Q4 2021 | $8,413,000 | +15.6% | 61,047 | +16.5% | 0.02% | +10.0% |
| Q3 2021 | $7,278,000 | -10.6% | 52,391 | -37.5% | 0.02% | +66.7% |
| Q2 2021 | $8,142,000 | +164.0% | 83,862 | +85.9% | 0.01% | +33.3% |
| Q1 2021 | $3,084,000 | -18.8% | 45,116 | +1.9% | 0.01% | -25.0% |
| Q4 2020 | $3,797,000 | -14.2% | 44,295 | -35.0% | 0.01% | -25.0% |
| Q3 2020 | $4,427,000 | -56.0% | 68,104 | -50.5% | 0.02% | -20.0% |
| Q2 2020 | $10,054,000 | +128.6% | 137,522 | +6.4% | 0.02% | +81.8% |
| Q1 2020 | $4,398,000 | +24.9% | 129,226 | -1.0% | 0.01% | -21.4% |
| Q4 2017 | $3,520,000 | – | 130,484 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |